Skip to content
  • Home
  • About us
    • Our Core Team
    • Scientific Advisors
    • Recognition
  • Science
    • AMD and EyecyteRPE
    • Retinitis pigmentosa and EyecytePR
  • Publications
  • Collaborations
    • Collaborations
    • Research Alliance
  • Updates
  • Careers
  • Contact Us
Eyestem
  • Home
  • About us
    • Our Core Team
    • Scientific Advisors
    • Recognition
  • Science
    • AMD and EyecyteRPE
    • Retinitis pigmentosa and EyecytePR
  • Publications
  • Collaborations
    • Collaborations
    • Research Alliance
  • Updates
  • Careers
  • Contact Us

Eyestem Research announces immediate availability of its Anti-Covid Screening (ACS) platform using iPSC derived lung progenitors

  • Home
  • update
  • Eyestem Research announces immediate availability of its Anti-Covid Screening (ACS) platform using iPSC derived lung progenitors

Post Author: eyetem@admin

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Post navigation

Previous PostEyestem Research, India’s premier cell therapy company, announces successful completion of pre-IND meeting with FDA
Next PostCSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad & Eyestem Research Private Limited, Bangalore announce a unique public-private collaboration in the fight against Covid-19
  • About Us
  • Science
  • Publications
  • Collaborations
  • Updates
  • Careers
  • Contact Us
  • Sitemap
Copyright© 2020 - Eyestem Research Pvt Ltd
  • Follow Us